Inclusion and Consideration of Patient Preferences in Amnog Early Benefit Assessments.

Patient perspective is becoming increasingly important in healthcare decision making. Patients should be involved as ‘end-users’ in the health technology assessment (HTA) processes to broaden the perspectives of the assessments and advice provided to decision makers1. Patients can provide information on their daily experience with disease, treatments and their needs, provide views on aspects not measured in studies, or state their preferences for various therapy aspects and treatment endpoints.